Skip to content

Clinical intervention and mechanism exploration of arginine combined with fish oil in elderly patients with sarcopenia

Clinical intervention and mechanism exploration of arginine combined with fish oil in elderly patients with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078053
Enrollment
Unknown
Registered
2023-11-28
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Intervention group:Arginine combined with fish oil intervention

Sponsors

The 925th Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Over 60 years old, agree to participate in the investigation and sign an informed consent form; ? Those who meet the standards for sarcopenia established by the 2019 Asian myopenia gravis working group (AWGS); ? Those who are able to eat orally and tolerate enteral nutrition.

Exclusion criteria

Exclusion criteria: ? Individuals with severe cognitive impairment, mental illness, etc. who are unable to participate in the test normally; ? Individuals who suffer from heart disease (including those equipped with pacemakers and heart stents), cannot participate in body composition testing and physical strength index testing after implantation of artificial joints, etc; ? Those with severe dysfunction of heart, liver, kidney and other organs; ? Patients with combined difficulty swallowing and eating; ? Long term use of thyroid drugs, steroids, and estrogen and progesterone; ? Those who have poor compliance and are deemed unsuitable by the research doctor; ? Patients with severe sepsis or systemic inflammatory response syndrome.

Design outcomes

Primary

MeasureTime frame
Physical examination indicators;NO;ADMA;Serum 25-hydroxyvitamin D;Fasting blood glucose;Fasting insulin concentration;renal function;blood fat;inflammatory factor;

Countries

China

Contacts

Public ContactLijia Yuan

The 925th Hospital, Huanghe Road, Huaxi District, Guiyang City, Guizhou Province

yljdoctor@126.com+86 152 8517 4268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026